Oncotarget

Research Papers:

Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse

Raymond L. Konger _, Ethel Derr-Yellin, Jeffrey B. Travers, Jesus A. Ocana and Ravi P. Sahu

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:98184-98199. https://doi.org/10.18632/oncotarget.21002

Metrics: PDF 1317 views  |   HTML 4266 views  |   ?  


Abstract

Raymond L. Konger1,2, Ethel Derr-Yellin1, Jeffrey B. Travers2,3, Jesus A. Ocana2 and Ravi P. Sahu3

1Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

2Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA

3Department of Pharmacology & Toxicology, Wright State University, Dayton, OH, USA

Correspondence to:

Raymond L. Konger, email: [email protected]

Keywords: contact hypersensitivity; immunosuppression; peroxisome proliferator-activated receptor Γ; ultraviolet; tumor necrosis factor alpha

Received: June 14, 2017    Accepted: August 26, 2017    Published: September 18, 2017

ABSTRACT

It is known that ultraviolet B (UVB) induces PPARγ ligand formation while loss of murine epidermal PPARγ (Pparg-/-epi) promotes UVB-induced apoptosis, inflammation, and carcinogenesis. PPARγ is known to suppress tumor necrosis factor-α (TNF-α) production. TNF-α is also known to promote UVB-induced inflammation, apoptosis, and immunosuppression. We show that Pparg-/-epi mice exhibit increased baseline TNF-α expression. Neutralizing Abs to TNF-α block the increased photo-inflammation and photo-toxicity that is observed in Pparg-/-epi mouse skin. Interestingly, the increase in UVB-induced apoptosis in Pparg-/-epi mice is not accompanied by a change in cyclobutane pyrimidine dimer clearance or in mutation burden. This suggests that loss of epidermal PPARγ does not result in a significant alteration in DNA repair capacity. However, loss of epidermal PPARγ results in marked immunosuppression using a contact hypersensitivity (CHS) model. This impaired CHS response was significantly alleviated using neutralizing TNF-α antibodies or loss of germline Tnf. In addition, the PPARγ agonist rosiglitazone reversed UVB-induced systemic immunosuppression (UV-IS) as well as UV-induced growth of B16F10 melanoma tumor cells in syngeneic mice. Finally, increased B16F10 tumor growth was observed when injected subcutaneously into Pparg-/-epi mice. Thus, we provide novel evidence that epidermal PPARγ is important for cutaneous immune function and the acute photoresponse.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21002